Skip to main content

Sight Sciences, Inc.

SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531177

In the last 90 days, Sight Sciences, Inc. insiders filed 0 open-market purchases and 6 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Sight Sciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of SGHT: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders6570+5
Shares16.6M16.8M+260.9K (+1.6%)
Value$87.6M$112.2M+$24.6M (+28.1%)

New holders (16)

Institutions that held Sight Sciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to SGHT in Q2 2024
InstitutionSharesValue% of portfolio
National Asset Management, Inc.185,082$1.23M0.03%
Nuveen Asset Management, LLC64,103$427.6K0.00%
Trexquant Investment LP49,326$329.0K0.01%
Goldman Sachs Group Inc35,057$233.8K0.00%
MetLife Investment Management21,423$142.9K0.00%
Corebridge Financial, Inc.18,900$126.1K0.00%
Manufacturers Life Insurance Company, The14,284$95.3K0.00%
Verition Fund Management LLC13,875$92.5K0.00%
Voya Investment Management LLC12,108$80.8K0.00%
Prudential Financial Inc12,005$80.1K0.00%
Price T Rowe Associates Inc11,271$76.0K0.00%
Mirae Asset Global ETFs Holdings Ltd.11,389$76.0K0.00%
Steele Capital Management, Inc.10,000$66.7K0.00%
EntryPoint Capital, LLC5,203$34.7K0.02%
nVerses Capital, LLC1,300$8.67K0.01%
SRS Capital Advisors, Inc.173$1.15K0.00%

Sold out (11)

Institutions that held Sight Sciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.